Cardiovascular Drugs News

News

EDARBYCLOR (azilsartan medoxomil and chlorthalidone) Now Available in U.S. Pharmacies for Patients
www.takeda.com | Feb 7, 2012
Deerfield, Ill., February 6, 2012 and Osaka, Japan, February 7, 2012 – Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced EDARBYCLOR (azilsartan medoxomil and chlorthalidone) is now available by prescription in U.S.

Boehringer Ingelheim, anti-hypertensi | Boehringer Ingelheim single combination of telmisartan and
www.pharmaasia.com | Feb 2, 2012
Boehringer Ingelheim has released a new anti-hypertensive drug (TWYNSTA) containing a unique combination of telmisartan and amlodipine. Very often, hypertension sufferers take up to four drugs to reach an acceptable blood pressure (BP) more effectively. The single-pill combination drug is taken

Lannett Company Inc Receives FDA Approval for
www.biospace.com | Jan 30, 2012
PHILADELPHIA---- Lannett Company, Inc. today announced it has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug

Blood Pressure Drug Shows Some Muscle - 05/11/2011
www.hopkinsmedicine.org | Jan 27, 2012
Using geriatric mice, a Johns Hopkins research team has shown that losartan, a commonly used blood pressure drug, not only improves regeneration of injured muscle but also protects against its wasting away from inactivity.

Calcium channel blockers protect against gout | 6minutes
www.6minutes.com.au | Jan 13, 2012
Calcium channel blockers can protect against gout while other antihypertensives including diuretics may increase the risk, a study suggests.

Heart Failure (HF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 | PRLog
www.prlog.org | Nov 10, 2011
Heart Failure (HF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018. The HF Therapeutics Market Shows Significant Growth Until 2018 - PR11720407

Carvedilol Reduces Intradialytic Hypertension : Internal Medicine News
www.internalmedicinenews.com | Jul 19, 2011
Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology

Blood pressure drug shows some muscle
www.eurekalert.org | May 12, 2011
Using geriatric mice, a Johns Hopkins research team has shown that losartan, a commonly used blood pressure drug, not only improves regeneration of injured muscle but also protects against its wasting away from inactivity.

Medical News: ACE Inhibitor May Trigger Breast Ca Recurrence - in Oncology/Hematology, Breast
www.medpagetoday.com | Apr 22, 2011
Breast cancer survivors had more than a 50% increase in the risk of recurrence if they were taking ACE inhibitors, a retrospective analysis of a large cohort study showed.

Frost & Sullivan explores the Cardiovascular Drugs potential in KSA and UAE
www.frost.com | Apr 19, 2011
The Healthcare Practice at Frost & Sullivan, a Global Growth Partnership Company, is pleased to host an Analyst Briefing titled ‘Cardiovascular